Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6,900
Closed -$433K – 4485
2026
Q1
$433K Sell
6,900
-20,200
-75% -$1.41M ﹤0.01% 2635
2025
Q4
$1.8M Buy
27,100
+17,100
+171% +$1.11M 0.01% 1375
2025
Q3
$672K Buy
+10,000
New +$791K ﹤0.01% 1727

Other funds holding DXCM

HRT Financial's DXCM Position: Q2 2026 in Review

HRT Financial opened a new position in DexCom (DXCM) in Q2 2026: 12,870 shares worth $866K. The stake represents ﹤0.01% of the portfolio and ranks #2256 among its holdings. This is a return to the name: HRT Financial previously reported a position in DXCM as recently as Q4 2025.

HRT Financial first reported a position in DXCM in Q3 2018 and has held it in 15 quarters since. The position peaked at $22.3M in Q4 2024. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • HRT Financial held 12,870 shares of DexCom worth $866K as of Q2 2026.
  • DexCom was a new HRT Financial position in Q2 2026.
  • DexCom made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2256 holding.
  • HRT Financial first reported a position in DexCom in Q3 2018 and has held it in 15 quarters since.
  • HRT Financial's DexCom position peaked at $22.3M in Q4 2024.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.